View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar I. Gyermekgyógyászati Klinika, MTA–SE Lendület Diabétesz Kutatócsoport Budapest Bókay J. u. 53. 1083
  • | 2 MTA–SE Gyermekgyógyászati és Nephrologiai Kutatócsoport Budapest
Open access

Az ultrahangvizsgálat jelentősége és fontossága a modern képalkotó vizsgálatok (CT, MR, izotóp, PET/CT) elterjedésével csökkent, nemritkán csak mint első tájékozódó vizsgálat jelenik meg. A legújabb sokszeletes spirál-CT-kkel a képalkotás másodpercek alatt elvégezhető, ami a jelentős sugárterheléssel járó vizsgálatok számának drámai növekedéséhez vezetett, gyermekkorban is. Ugyanakkor nem feledkezhetünk meg arról, hogy az elmúlt években jelentős fejlődés történt az ultrahang-technológiában, a képminőség egyre jobb. A gyermekek ideális alanyai a vizsgálatnak, miután az esetek nagy részében testtömegük kisebb, kevesebb zsírt tartalmaz, így könnyen vizsgálhatók magas frekvenciájú transzducerrel, aminek következtében sokkal részletgazdagabb, jobb felbontású képek nyerhetők, mint általában felnőtteknél. Megfelelő készülék és gyakorlott, gyermekradiológiában tapasztalt vizsgáló esetében csaknem valamennyi testtájék vizsgálható, mindenképpen első választandó módszer, amely legtöbbször elegendő (esetleg röntgenvizsgálattal kiegészítve) a megfelelő diagnózis felállítására. A közlemény azokkal a lehetőségekkel foglalkozik, ahol a modern ultrahangkészülékek birtokában az ultrahangvizsgálat elegendő a pontos diagnózishoz. Orv. Hetil., 2014, 155(4), 132–140.

  • Guariguata, L.: By the numbers: New estimates from the IDF Diabetes Atlas Update for 2012. Diabetes Res. Clin. Pract., 2012, 98, 524–525.

    Guariguata L. , 'By the numbers: New estimates from the IDF Diabetes Atlas Update for 2012 ' (2012 ) 98 Diabetes Res. Clin. Pract. : 524 -525.

    • Search Google Scholar
  • Whiting, D. R., Guariguata, L., Weil, C., et al.: IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract., 2011, 94, 311–321.

    Weil C. , 'IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 ' (2011 ) 94 Diabetes Res. Clin. Pract. : 311 -321.

    • Search Google Scholar
  • Jermendy, G. (ed.): Diagnosis of diabetes mellitus, treatment of patients and long-term follow up. [A diabetes mellitus kórismézése, a cukorbetegek kezelése és gondozása a felnőttkorban. A Magyar Diabetes Társaság szakmai irányelve, 2011.] Diabetologia Hungarica, 2011, 19 (Suppl. 1), 5–72. [Hungarian]

    Jermendy G. , 'Diagnosis of diabetes mellitus, treatment of patients and long-term follow up. [A diabetes mellitus kórismézése, a cukorbetegek kezelése és gondozása a felnőttkorban. A Magyar Diabetes Társaság szakmai irányelve, 2011.] ' (2011 ) 19 Diabetologia Hungarica : 5 -72.

    • Search Google Scholar
  • Patterson, C. C., Dahlquist, G. G., Gyürüs, E., et al.: Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet, 2009, 373, 2027–2033.

    Gyürüs E. , 'Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study ' (2009 ) 373 Lancet : 2027 -2033.

    • Search Google Scholar
  • Pinhas-Hamiel, O., Zeitler, P.: Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet, 2007, 369, 1823–1831.

    Zeitler P. , 'Acute and chronic complications of type 2 diabetes mellitus in children and adolescents ' (2007 ) 369 Lancet : 1823 -1831.

    • Search Google Scholar
  • Narayan, K. M., Boyle, J. P., Thompson, T. J., et al.: Lifetime risk for diabetes mellitus in the United States. JAMA, 2003, 290, 1884–1890.

    Thompson T. J. , 'Lifetime risk for diabetes mellitus in the United States ' (2003 ) 290 JAMA : 1884 -1890.

    • Search Google Scholar
  • Skrivarhaug, T., Bangstad, H. J., Stene, L. C., et al.: Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway. Pediatr. Diabetes, 2006, 7, 239–246.

    Stene L. C. , 'Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway ' (2006 ) 7 Pediatr. Diabetes : 239 -246.

    • Search Google Scholar
  • Foley, R. N., Murray, A. M., Li, S., et al.: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J. Am. Soc. Nephrol., 2005, 16, 489–495.

    Li S. , 'Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 ' (2005 ) 16 J. Am. Soc. Nephrol. : 489 -495.

    • Search Google Scholar
  • U.S. Renal Data System, USRDS 2012. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012.

  • Andersen, A. R., Christiansen, J. S., Andersen, J. K., et al.: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia, 1983, 25, 496–501.

    Andersen J. K. , 'Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study ' (1983 ) 25 Diabetologia : 496 -501.

    • Search Google Scholar
  • Krakoff, J., Lindsay, R. S., Looker, H. C., et al.: Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care, 2003, 26, 76–81.

    Looker H. C. , 'Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes ' (2003 ) 26 Diabetes Care : 76 -81.

    • Search Google Scholar
  • Svensson, M., Sundkvist, G., Arnqvist, H. J., et al.: Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care, 2003, 26, 2903–2909.

    Arnqvist H. J. , 'Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS) ' (2003 ) 26 Diabetes Care : 2903 -2909.

    • Search Google Scholar
  • Viberti, G. C., Jarrett, R. J., Mahmud, U., et al.: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet, 1982, 319, 1430–1432.

    Mahmud U. , 'Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus ' (1982 ) 319 Lancet : 1430 -1432.

    • Search Google Scholar
  • Gellman, D. D., Pirani, C. L., Soothill, J. F., et al.: Diabetic nephropathy: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore), 1959, 38, 321–367.

    Soothill J. F. , 'Diabetic nephropathy: a clinical and pathologic study based on renal biopsies ' (1959 ) 38 Medicine (Baltimore) : 321 -367.

    • Search Google Scholar
  • Mogensen, C. E.: How to protect the kidney in diabetic patients: with special reference to IDDM. Diabetes, 1997, 46 (Suppl. 2), S104–S111.

    Mogensen C. E. , 'How to protect the kidney in diabetic patients: with special reference to IDDM ' (1997 ) 46 Diabetes : S104 -S111.

    • Search Google Scholar
  • Wada, J., Makino, H.: Inflammation and the pathogenesis of diabetic nephropathy. Clin. Sci. (Lond.), 2013, 124, 139–152.

    Makino H. , 'Inflammation and the pathogenesis of diabetic nephropathy ' (2013 ) 124 Clin. Sci. (Lond.) : 139 -152.

    • Search Google Scholar
  • Chiarelli, F., Verrotti, A., Mohn, A., et al.: The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications. Ann. Med., 1997, 29, 439–445.

    Mohn A. , 'The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications ' (1997 ) 29 Ann. Med. : 439 -445.

    • Search Google Scholar
  • Amin, R., Turner, C., van Aken, S., et al.: The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int., 2005, 68, 1740–1749.

    Aken S. , 'The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study ' (2005 ) 68 Kidney Int. : 1740 -1749.

    • Search Google Scholar
  • Schultz, C. J., Konopelska-Bahu, T., Dalton, R. N., et al.: Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care, 1999, 22, 495–502.

    Dalton R. N. , 'Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group ' (1999 ) 22 Diabetes Care : 495 -502.

    • Search Google Scholar
  • Eppens, M. C., Craig, M. E., Cusumano, J., et al.: Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care, 2006, 29, 1300–1306.

    Cusumano J. , 'Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes ' (2006 ) 29 Diabetes Care : 1300 -1306.

    • Search Google Scholar
  • Dunger, D. B., Schwarze, C. P., Cooper, J. D., et al.: Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabet. Med., 2007, 24, 131–136.

    Cooper J. D. , 'Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? ' (2007 ) 24 Diabet. Med. : 131 -136.

    • Search Google Scholar
  • Bangstad, H. J., Østerby, R., Rudberg, S., et al.: Kidney function and glomerulopathy over 8 years in young patients with type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia, 2002, 45, 253–261.

    Rudberg S. , 'Kidney function and glomerulopathy over 8 years in young patients with type I (insulin-dependent) diabetes mellitus and microalbuminuria ' (2002 ) 45 Diabetologia : 253 -261.

    • Search Google Scholar
  • Hirschberg, R.: Effects of growth hormone and IGF-I on glomerular ultrafiltration in growth hormone-deficient rats. Regul. Pept., 1993, 48, 241–250.

    Hirschberg R. , 'Effects of growth hormone and IGF-I on glomerular ultrafiltration in growth hormone-deficient rats ' (1993 ) 48 Regul. Pept. : 241 -250.

    • Search Google Scholar
  • Cummings, E. A., Sochett, E. B., Dekker, M. G., et al.: Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes, 1998, 47, 1341–1346.

    Dekker M. G. , 'Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes ' (1998 ) 47 Diabetes : 1341 -1346.

    • Search Google Scholar
  • Donaghue, K. C., Chiarelli, F., Trotta, D., et al.: ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications. Pediatr. Diabetes, 2007, 8, 163–170.

    Trotta D. , 'ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications ' (2007 ) 8 Pediatr. Diabetes : 163 -170.

    • Search Google Scholar
  • Tabaei, B. P., Al-Kassab, A. S., Ilag, L. L., et al.: Does microalbuminuria predict diabetic nephropathy? Diabetes Care, 2001, 24, 1560–1566.

    Ilag L. L. , 'Does microalbuminuria predict diabetic nephropathy? ' (2001 ) 24 Diabetes Care : 1560 -1566.

    • Search Google Scholar
  • Perkins, B. A., Ficociello, L. H., Ostrander, B. E., et al.: Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J. Am. Soc. Nephrol., 2007, 18, 1353–1361.

    Ostrander B. E. , 'Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes ' (2007 ) 18 J. Am. Soc. Nephrol. : 1353 -1361.

    • Search Google Scholar
  • Nakamura, T., Ushiyama, C., Suzuki, S., et al.: Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol. Dial. Transplant., 2000, 15, 1379–1383.

    Suzuki S. , 'Urinary excretion of podocytes in patients with diabetic nephropathy ' (2000 ) 15 Nephrol. Dial. Transplant. : 1379 -1383.

    • Search Google Scholar
  • Bolignano, D., Lacquaniti, A., Coppolino, G., et al.: Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin. J. Am. Soc. Nephrol., 2009, 4, 337–344.

    Coppolino G. , 'Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease ' (2009 ) 4 Clin. J. Am. Soc. Nephrol. : 337 -344.

    • Search Google Scholar
  • Nielsen, S. E., Schjoedt, K. J., Astrup, A. S., et al.: Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet. Med., 2010, 27, 1144–1150.

    Astrup A. S. , 'Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril ' (2010 ) 27 Diabet. Med. : 1144 -1150.

    • Search Google Scholar
  • Zachwieja, J., Soltysiak, J., Fichna, P., et al.: Normal-range albuminuria does not exclude nephropathy in diabetic children. Pediatr. Nephrol., 2010, 25, 1445–1451.

    Fichna P. , 'Normal-range albuminuria does not exclude nephropathy in diabetic children ' (2010 ) 25 Pediatr. Nephrol. : 1445 -1451.

    • Search Google Scholar
  • American Diabetes Association: Standards of medical care in diabetes – 2013. Diabetes Care, 2013, 36 (Suppl. 1), S11–S66.

    'Standards of medical care in diabetes – 2013 ' (2013 ) 36 Diabetes Care : S11 -S66.

  • Rudberg, S., Østerby, R., Bangstad, H. J., et al.: Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus. Diabetologia, 1999, 42, 589–595.

    Bangstad H. J. , 'Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus ' (1999 ) 42 Diabetologia : 589 -595.

    • Search Google Scholar
  • Yüksel, H., Darcan, S., Kabasakal, C., et al.: Effect of enalapril on proteinuria, phosphaturia, and calciuria in insulin-dependent diabetes. Pediatr. Nephrol., 1998, 12, 648–650.

    Kabasakal C. , 'Effect of enalapril on proteinuria, phosphaturia, and calciuria in insulin-dependent diabetes ' (1998 ) 12 Pediatr. Nephrol. : 648 -650.

    • Search Google Scholar
  • Brosius, F. C. 3rd., Alpers, C. E., Bottinger, E. P., et al.: Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol., 2009, 20, 2503–2512.

    Bottinger E. P. , 'Mouse models of diabetic nephropathy ' (2009 ) 20 J. Am. Soc. Nephrol. : 2503 -2512.

    • Search Google Scholar
  • Takahashi, N., Boysen, G., Li, F., et al.: Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. Kidney Int., 2007, 71, 266–271.

    Li F. , 'Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate ' (2007 ) 71 Kidney Int. : 266 -271.

    • Search Google Scholar
  • Keppler, A., Gretz, N., Schmidt, R., et al.: Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney Int., 2007, 71, 74–78.

    Schmidt R. , 'Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay ' (2007 ) 71 Kidney Int. : 74 -78.

    • Search Google Scholar
  • Qi, Z., Whitt, I., Mehta, A., et al.: Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am. J. Physiol. Renal Physiol., 2004, 286, F590–F596.

    Mehta A. , 'Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance ' (2004 ) 286 Am. J. Physiol. Renal Physiol. : F590 -F596.

    • Search Google Scholar
  • Kato, M., Zhang, J., Wang, M., et al.: MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. USA, 2007, 104, 3432–3437.

    Wang M. , 'MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors ' (2007 ) 104 Proc. Natl. Acad. Sci. USA : 3432 -3437.

    • Search Google Scholar
  • Putta, S., Lanting, L., Sun, G., et al.: Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J. Am. Soc. Nephrol., 2012, 23, 458–469.

    Sun G. , 'Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy ' (2012 ) 23 J. Am. Soc. Nephrol. : 458 -469.

    • Search Google Scholar
  • Krupa, A., Jenkins, R., Luo., D. D., et al.: Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J. Am. Soc. Nephrol., 2010, 21, 438–447.

    Luo. D. D. , 'Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy ' (2010 ) 21 J. Am. Soc. Nephrol. : 438 -447.

    • Search Google Scholar
  • Nguyen, D., Ping, F., Mu, W., et al.: Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton), 2006, 11, 226–231.

    Mu W. , 'Macrophage accumulation in human progressive diabetic nephropathy ' (2006 ) 11 Nephrology (Carlton) : 226 -231.

    • Search Google Scholar
  • Lim, A. K., Ma, F. Y., Nikolic-Paterson, D. J., et al.: Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice. Diabetologia, 2009, 52, 1669–1679.

    Nikolic-Paterson D. J. , 'Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice ' (2009 ) 52 Diabetologia : 1669 -1679.

    • Search Google Scholar
  • Moriya, R., Manivel, J. C., Mauer, M.: Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in type 1 diabetic patients. Diabetologia, 2004, 47, 82–88.

    Mauer M. , 'Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in type 1 diabetic patients ' (2004 ) 47 Diabetologia : 82 -88.

    • Search Google Scholar
  • Lim, A. K., Ma, F. Y., Nikolic-Paterson, D. J., et al.: Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury. Diabetologia, 2010, 53, 1772–1782.

    Nikolic-Paterson D. J. , 'Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury ' (2010 ) 53 Diabetologia : 1772 -1782.

    • Search Google Scholar
  • Eller, K., Kirsch, A., Wolf, A. M., et al.: Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes, 2011, 60, 2954–2962.

    Wolf A. M. , 'Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy ' (2011 ) 60 Diabetes : 2954 -2962.

    • Search Google Scholar
  • McAuliffe, A. V., Brooks, B. A., Fisher, E. J., et al.: Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion. Nephron, 1998, 80, 277–284.

    Fisher E. J. , 'Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion ' (1998 ) 80 Nephron : 277 -284.

    • Search Google Scholar
  • Tuttle, K. R.: Could renin inhibition be the next step forward in the treatment of diabetic kidney disease? Nat. Clin. Pract. Endocrinol. Metab., 2009, 5, 20–21.

    Tuttle K. R. , 'Could renin inhibition be the next step forward in the treatment of diabetic kidney disease? ' (2009 ) 5 Nat. Clin. Pract. Endocrinol. Metab. : 20 -21.

    • Search Google Scholar
  • Tuttle, K. R.: Protein kinase C-beta inhibition for diabetic kidney disease. Diabetes Res. Clin. Pract., 2008, 82 (Suppl. 1), S70–S74.

    Tuttle K. R. , 'Protein kinase C-beta inhibition for diabetic kidney disease ' (2008 ) 82 Diabetes Res. Clin. Pract. : S70 -S74.

    • Search Google Scholar
  • Tuttle, K. R., Bakris, G. L., Toto, R. D., et al.: The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care, 2005, 28, 2686–2690.

    Toto R. D. , 'The effect of ruboxistaurin on nephropathy in type 2 diabetes ' (2005 ) 28 Diabetes Care : 2686 -2690.

    • Search Google Scholar
  • Tuttle, K. R., McGill, J. B., Haney, D. J., et al.: Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease. Clin. J. Am. Soc. Nephrol., 2007, 2, 631–636.

    Haney D. J. , 'Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease ' (2007 ) 2 Clin. J. Am. Soc. Nephrol. : 631 -636.

    • Search Google Scholar
  • Aiello, L. P., Davis, M. D., Girach, A., et al.: Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology, 2006, 113, 2221–2230.

    Girach A. , 'Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy ' (2006 ) 113 Ophthalmology : 2221 -2230.

    • Search Google Scholar
  • Ramachandrarao, S. P., Zhu, Y., Ravasi, T., et al.: Pirfenidone is renoprotective in diabetic kidney disease. J. Am. Soc. Nephrol., 2009, 20, 1765–1775.

    Ravasi T. , 'Pirfenidone is renoprotective in diabetic kidney disease ' (2009 ) 20 J. Am. Soc. Nephrol. : 1765 -1775.

    • Search Google Scholar
  • Cho, M. E., Smith, D. C., Branton, M. H., et al.: Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol., 2007, 2, 906–913.

    Branton M. H. , 'Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis ' (2007 ) 2 Clin. J. Am. Soc. Nephrol. : 906 -913.

    • Search Google Scholar
  • Gambaro, G., Cavazzana, A. O., Luzi, P., et al.: Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int., 1992, 42, 285–291.

    Luzi P. , 'Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats ' (1992 ) 42 Kidney Int. : 285 -291.

    • Search Google Scholar
  • Gambaro, G., Kinalska, I., Oksa, A., et al.: Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial. J. Am. Soc. Nephrol., 2002, 13, 1615–1625.

    Oksa A. , 'Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial ' (2002 ) 13 J. Am. Soc. Nephrol. : 1615 -1625.

    • Search Google Scholar
  • Lambers Heerspink, H. J., Fowler, M. J., Volgi, J., et al.: Rationale for and study design of the sulodexide trials in type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy. Diabet. Med., 2007, 24, 1290–1295.

    Volgi J. , 'Rationale for and study design of the sulodexide trials in type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy ' (2007 ) 24 Diabet. Med. : 1290 -1295.

    • Search Google Scholar
  • Pergola, P. E., Raskin, P., Toto, R. D., et al.: Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N. Engl. J. Med., 2011, 365, 327–336.

    Toto R. D. , 'Bardoxolone methyl and kidney function in CKD with type 2 diabetes ' (2011 ) 365 N. Engl. J. Med. : 327 -336.

    • Search Google Scholar
  • De Zeeuw, D., Akizawa, T., Agarwal, R., et al.: Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON). Am. J. Nephrol., 2013, 37, 212–222.

    Agarwal R. , 'Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON) ' (2013 ) 37 Am. J. Nephrol. : 212 -222.

    • Search Google Scholar
  • Gil-Bernabe, P., D’Alessandro-Gabazza, C. N., Toda, M., et al.: Exogenous activated protein C inhibits the progression of diabetic nephropathy. J. Thromb. Haemost., 2012, 10, 337–346.

    Toda M. , 'Exogenous activated protein C inhibits the progression of diabetic nephropathy ' (2012 ) 10 J. Thromb. Haemost. : 337 -346.

    • Search Google Scholar
  • Xue, M., Dervish, S., Harrison, L. C., et al.: Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice. J. Biol. Chem., 2012, 287, 16356–16364.

    Harrison L. C. , 'Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice ' (2012 ) 287 J. Biol. Chem. : 16356 -16364.

    • Search Google Scholar
  • Swaney, J. S., Chapman, C., Correa, L. D., et al.: A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br. J. Pharmacol., 2010, 160, 1699–1713.

    Correa L. D. , 'A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model ' (2010 ) 160 Br. J. Pharmacol. : 1699 -1713.

    • Search Google Scholar
  • Flaquer, M., Franquesa, M., Vidal, A., et al.: Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia, 2012, 55, 2059–2068.

    Vidal A. , 'Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes ' (2012 ) 55 Diabetologia : 2059 -2068.

    • Search Google Scholar
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 59 54 3
PDF Downloads 101 100 12